» Authors » Frederik B J M Thunnissen

Frederik B J M Thunnissen

Explore the profile of Frederik B J M Thunnissen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 601
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Swarts D, van Suylen R, den Bakker M, van Oosterhout M, Thunnissen F, Volante M, et al.
Am J Surg Pathol . 2014 Jul; 38(10):1429-36. PMID: 25046341
Pulmonary carcinoids are neuroendocrine tumors histopathologically subclassified into typical (TC; no necrosis, <2 mitoses per 2 mm) and atypical (AC; necrosis or 2 to 10 mitoses per 2 mm). The...
2.
Swarts D, Claessen S, Jonkers Y, van Suylen R, Dingemans A, de Herder W, et al.
Am J Pathol . 2011 Jul; 179(3):1129-37. PMID: 21763262
Carcinoids are slow-growing neuroendocrine tumors that, in the lung, can be subclassified as typical (TC) or atypical (AC). To identify genetic alterations that improve the prediction of prognosis, we investigated...
3.
Verhagen A, Bulten J, Shirango H, Thunnissen F, van der Drift M, van der Bruggen W, et al.
J Thorac Oncol . 2010 Jul; 5(8):1201-5. PMID: 20588201
Introduction: In early stage non-small cell lung cancer (NSCLC), presence of lymphatic micrometastases and isolated tumor cells, primarily detected by immunohistochemistry, is suggested to be a prognostic factor. However, there...
4.
den Bakker M, Willemsen S, Grunberg K, Noorduijn L, van Oosterhout M, van Suylen R, et al.
Histopathology . 2010 May; 56(3):356-63. PMID: 20459535
Aims: To test the hypothesis that the published morphological criteria permit reliable segregation of small cell carcinoma of the lung (SCLC) and large cell neuroendocrine carcinoma (LCNEC) cases by determining...
5.
van der Drift M, Hol B, Klaassen C, Prinsen C, van Aarssen Y, Donders R, et al.
Lung Cancer . 2009 Jul; 68(2):283-7. PMID: 19632736
Introduction: Circulating plasma DNA is present in a considerably higher concentration in lung cancer patients than in controls. Conflicting data are reported about circulating DNA as a prognostic factor. The...
6.
Saad A, Yeap B, Thunnissen F, Pinkus G, Pinkus J, Loda M, et al.
Cancer . 2008 Aug; 113(8):2129-38. PMID: 18720359
Background: To the authors' knowledge, there are no reliable markers able to identify patients with nonsmall cell lung cancer (NSCLC) that will develop metastases to the brain. The authors investigated...
7.
Bolster M, Peer P, Bult P, Thunnissen F, Schapers R, Meijer J, et al.
Ann Surg Oncol . 2006 Oct; 14(1):181-9. PMID: 17028772
Background: In this multi-institutional prospective study, we evaluated whether we could identify risk factors predictive for non-sentinel lymph node (non-SN) metastases in breast cancer patients with a positive sentinel lymph...
8.
van der Drift M, van der Wilt G, Thunnissen F, Janssen J
Chest . 2005 Jul; 128(1):394-400. PMID: 16002962
Study Objectives: The value of obtaining washings during fiberoptic bronchoscopy in the workup of lung cancer is controversial. Moreover, the optimal timing of washing relative to biopsy and brushing is...
9.
Comhair S, Xu W, Ghosh S, Thunnissen F, Almasan A, Calhoun W, et al.
Am J Pathol . 2005 Mar; 166(3):663-74. PMID: 15743779
Airway hyperresponsiveness and remodeling are defining features of asthma. We hypothesized that impaired superoxide dismutase (SOD) antioxidant defense is a primary event in the pathophysiology of hyperresponsiveness and remodeling that...
10.
Xu W, Kaneko F, Zheng S, Comhair S, Janocha A, Goggans T, et al.
FASEB J . 2004 Sep; 18(14):1746-8. PMID: 15364894
Pulmonary arterial hypertension (PAH), a fatal disease of unknown etiology characterized by impaired regulation of pulmonary hemodynamics and vascular growth, is associated with low levels of pulmonary nitric oxide (NO)....